Approval · Notice of Compliance 21720 · 2019
ONSTRYV: Notice of Compliance 21720
Issued January 10, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21720
- Date
- January 10, 2019
- Company
- Valeo Pharma Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- SAFINAMIDE 50 MG per TAB
- SAFINAMIDE 100 MG per TAB